alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Amendment to PSS World Savings Plan



 EXHIBIT 10.8a 
 NOVEMBER 2011 AMENDMENT 
 TO THE 

PSS WORLD MEDICAL, INC. SAVINGS PLAN 
 This November 2011 Amendment (the “Amendment”) to the PSS World Medical, Inc. Savings Plan is made and entered into by PSS World Medical, Inc. (the “Company”), this 30th day of
November, and is effective as of December 1, 2011. 
 WITNESSETH: 

WHEREAS, the Company has previously adopted the PSS World Medical, Inc. Savings Plan (the “Plan”); and 

WHEREAS, the Company is authorized and empowered to amend the Plan; and 

WHEREAS, the Company desires to amend the Plan to include the name of an additional employer recently acquired by the Company as
an “Employer” within the meaning of the Plan and to amend the Plan to credit Participants’ years of service with such employer as Years of Service under the Plan. 

NOW, THEREFORE, the Plan shall be amended as follows: 
 1. Section 1.28 of the Plan shall be amended in its entirety to read as follows: 
 “1.28 ‘Employer’ shall mean the Company, Gulf South Medical Supply, Inc., PSS Service, Inc., World Med Shared Services, Inc., Physician Sales & Service, Inc., Physician
Sales & Service Limited Partnership, Proclaim, Inc., PSS Holding, Inc., Ancillary Management Solutions, Inc., Cascade Medical Supply, ThriftyMed, Inc., ClaimOne, LLC, Dispensing Solutions, Inc., Linear Medical Solutions, LLC, Stat RX USA,
LLC, BottomLine Medical Solutions, LLC, Theratech, Inc., Standard Medical Supply, Inc. and any other subsidiary, related corporation, or other entity that adopts this Plan with the consent of the Company.” 

2. Section 1.71 of the Plan shall be amended by the addition of a new subparagraph (j), which shall read in its entirety as follows:

 “(j) For each Employee who was employed by Standard Medical Supply Inc. on October 14, 2011, such
Employee’s ‘Years of Service’ shall include, for all purposes of the Plan, service with Standard Medical Supply Inc. and each of its subsidiaries.” 







 IN WITNESS WHEREOF, this Amendment has been executed and is effective as of the date
set forth hereinabove. All of the provisions of the Plan not specifically mentioned in this Amendment shall be considered modified to the extent necessary to be consistent with the changes made in this Amendment. 

 

			
	PSS WORLD MEDICAL, INC.
		
	By:	 	 /s/ David D. Klarner

	Its:	 	Vice President and Treasurer
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               DEC-31-2000
<CASH>                                          17,777
<SECURITIES>                                         0
<RECEIVABLES>                                1,359,404
<ALLOWANCES>                                  (13,945)
<INVENTORY>                                    987,810
<CURRENT-ASSETS>                             2,356,814
<PP&E>                                       3,954,205
<DEPRECIATION>                             (1,198,016)
<TOTAL-ASSETS>                               5,998,178
<CURRENT-LIABILITIES>                        1,973,212
<BONDS>                                      1,000,175
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             1
<OTHER-SE>                                   1,974,935
<TOTAL-LIABILITY-AND-EQUITY>                 5,998,178
<SALES>                                     22,151,408
<TOTAL-REVENUES>                            22,194,216
<CGS>                                       21,520,984
<TOTAL-COSTS>                               21,727,342
<OTHER-EXPENSES>                                 1,808
<LOSS-PROVISION>                                 1,651
<INTEREST-EXPENSE>                              92,838
<INCOME-PRETAX>                                370,577
<INCOME-TAX>                                   138,593
<INCOME-CONTINUING>                            231,984
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   231,984
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0


</TABLE>
<PAGE>

                                  EXHIBIT 31.2

                                 CERTIFICATIONS

I, Bernard Denoyer, certify that:

1) I have reviewed this quarterly report on Form 10-QSB/A of Callisto
Pharmaceuticals, Inc.

2) Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3) Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4) The registrant's other certifying officers and I am responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this quarterly report is being prepared;

b) Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

c) Disclosed in this report any change in the registrant's internal control over
financial reporting that occurred during the registrant's most recent fiscal
quarter (the registrant's fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and

5) The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions);

a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and b) Any fraud, whether or not
material, that involves management or other employees who have a significant
role in the registrant's internal control over financial reporting.

Date: December 1, 2003



                                        /s/ Bernard F. Denoyer
                                        ----------------------
                                        Bernard F. Denoyer
                                        Principal Financial Officer
**EXHIBIT 13.1**

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,**

**AS ENACTED PURSUANT TO**

**SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002**

In connection with the Annual Report of Guangshen Railway Company Limited, or the Company, on Form 20-F for the period endingDecember 31, 2013, as filed with the Securities and Exchange Commission on the date hereof, or the Report, the undersigned hereby certify that to the best of my knowledge: 

1. the Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and 

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of theCompany. 

Date: April 24, 2014 

 

A signed original of this written statement required by Section 906 has been provided to Guangshen Railway CompanyLimited and will be retained by Guangshen Railway Company Limited and furnished to the Securities and Exchange Commission or its staff upon request. 

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,**

**AS ENACTED PURSUANT TO**

**SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002**

In connection with the Annual Report of Guangshen Railway Company Limited, or the Company, on Form 20-F for the period endingDecember 31, 2013, as filed with the Securities and Exchange Commission on the date hereof, or the Report, the undersigned hereby certify that to the best of my knowledge: 

1. the Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and 

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of theCompany. 

Date: April 24, 2014 

 

/s/ Shen Yi
Shen YiGeneral Manager
A signed original of this written statement required by Section 906 has been provided to Guangshen Railway CompanyLimited and will be retained by Guangshen Railway Company Limited and furnished to the Securities and Exchange Commission or its staff upon request. 

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,**

**AS ENACTED PURSUANT TO**

**SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002**

In connection with the Annual Report of Guangshen Railway Company Limited, or the Company, on Form 20-F for the period endingDecember 31, 2013, as filed with the Securities and Exchange Commission on the date hereof, or the Report, the undersigned hereby certify that to the best of my knowledge: 

1. the Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and 

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of theCompany. 

Date: April 24, 2014 

 

/s/ Tang Xiangdong
Tang XiangdongChief Accountant
A signed original of this written statement required by Section 906 has been provided to Guangshen Railway CompanyLimited and will be retained by Guangshen Railway Company Limited and furnished to the Securities and Exchange Commission or its staff upon request.
First American Title Company
5 First American Way, Santa Ana, CA 92707
Phone - (714)250-5381 Fax - (714)913-6372
 AMENDED/SUPPLEMENTAL ESCROW INSTRUCTIONS
 To: First American Title Company
    
    December 30, 2008File No:   OSA-3152741 (jg)Re: APN 349-240-043-9, Lake Elsinore, CA
  Close of Escrow: January 15, 2009.
  TSG Little Valley, L.P., a California
limited partnershipBy:
    
    Peloton Partners, L.P., a Californialimited partnershipBy:
    
    Portfolio Partners, Inc., a CaliforniacorporationBy::
    
    /s/ Stevan J. Gromet
STEVAN J. GROMET
Its: President
 Page 1 of 2




---



##### 



First American Title Company
    
    File No.:OSA-3152741 (jg )
 Shopoff Advisors, L.P., a Delaware
limited partnershipBy:
    
    The Shopoff Corporation, a Delawarecorporation, its General PartnerBy::
    
    /s/ William A. Shopoff
William A. Shopoff

Its: President and CEO
    ,
 Page 2 of 2
December 20, 2016

U.S. Department of Transportation

Docket Operations, M-30

West Building ground floor, 

Room W12-140

1200 New Jersey Avenue, SE 

Washington, DC 20590

Subject: Request for extension of exemption

(Docket Number FAA-2010-1227)

SimCom International Inc., Center number Q8PX038K, is requesting and extension of 

our Exemption No. 11474 which allows relief from the requirements of 14 CFR Part 

91.531(a)(2); 91.531(a)(1); 91.9(a) to the extent necessary to allow SimCom 

International, Inc. to train, test, and certificate pilots to fly the Cessna Citation, CE500 

series aircraft, Single-Pilot.

We assert that the conditions and reasons regarding the public interest and safety made in 

our original application remain unchanged.

Further to our petition we advise that SimCom has officially changed its name and been 

issued a revised training certificate under the name SimCom International, Inc. dba 

SimCom Aviation Training Phoenix effective May 23, 2016.

We would also like to request a fax copy of the approval and then the original mailed to 

our office address.

Sincerely,

Gary W. Santos

Training Center Manager 

SimCom International, Inc.

7860 E. McClain Dr. Suite 1

Scottsdale, AZ 85260

gsantos@simulator.com

(480)905-3040

7860 East McClain, Suite 1, Scottsdale, Arizona 85260 

(480) 905-3040 / (800)293-3035 (480) 951-2709 Fax
PERRY'S MAJESTIC BEER, INC.
                                 100 PLAZA DRIVE
                                  SECOND FLOOR
                           SECAUCUS, NEW JERSEY 07094
                           (201) 866-1300 (telephone)
                           (201) 866-5750 (telecopier)

                                December 23, 1998

James B. Hovis, President
X-Treem Products Corporation
100 Plaza Drive
Second Floor
Secaucus, New Jersey  07094

Dear Jim:

     This letter serves as written notice to X-Treem Products Corporation (the
"Company") of the election by Perry's Majestic Beer, Inc. (the "Licensee") to
exercise the Option, as defined in the License Agreement between the Company and
the Licensee dated December 1, 1998 (the "License Agreement"), pursuant to
Section 2.3 of the License Agreement.

     The Company hereby acknowledges that this letter was accompanied by a
promissory note by the Licensee in favor of the Company in the original
principal amount of the Option Price, as defined in the License Agreement, and
that, therefore, the Licensee has exercised the Option and the License Agreement
is hereby terminated.

                                                     Very truly yours,

                                                     PERRY'S MAJESTIC BEER, INC.



                                                     By: /s/ Robert J. Sipper
                                                         ----------------------
                                                          Robert J. Sipper, COO

ACCEPTED AND AGREED TO this 23rd day of December, 1998.

X-TREEM PRODUCTS CORPORATION


By: /s/ James B. Hovis
    ----------------------
    James B. Hovis, President
NORTHERN SIERRA AIR QUALITY MANAGEMENT DISTRICT 

### Gretchen Bennitt, Executive Director D ISTRICT HEADQUARTERS NORTHERN F IELD OF FIC E 200 Litton Dri ve, Suite 320 257 E
. Sierra, Unit E Mailing Address: P .O. Box 2509 Mailing Address: P
. O. Box 2227 Grass Valley, CA 95945 Portola, CA 96122 (530) 274-9360 I FAX: (530) 274- 7546 (530) 832-0102 / FAX: (530) 832 - 0101 Email: office@myaird istrict. com Web Site: www.mya i rdistrict.com Email : ryan@myairdistrict.com

Jul y 9 , 2014 Gerardo C
. Rios Chief, Air Permits Office (Air-3) EPA Region 9 75 H awthorne Street S an Franc i sco, CA 94105 SUBJECT: 40 CFR Part 51 , Appendix S Applicability Dear Mr. Rio s: 

### AIE<CIE~VED 

## JUL 1 

## 4 2014



# - - - --- - -- -- - - - -

Thi s letter is in re s p o n se to your request for additional info rmatio n regarding compliance with the federal new so urce review (NSR) re quiremen ts for ozone, in the int erim , wh ile requirements consistent with the national ambient air quality s tandard s (NAA QS ) for ozo ne are incorporated in to our NSR program. In particular , yo u have asked u s to acknowledge the app licab il ity of 40 C o de of Federal Regulations (CFR) part 51, Appendix S to n e w and mod ified major so urce s during t h e period prior t o EPA's approval of a NSR progra m app lic able to our ozone n o nattainme nt area . As you are aware, a portion of the Northern Sierra Air Quality Management Di str i c t is currently classified as a moderate nonattainment area under the 1997 ozone NAAQS an d as a marginal nonattainment area under the 2008 ozone NAAQS. A new NSR program s ubmittal was du e to EPA by Jun e 13,2013 for the 1997 ozone NAAQS, while an NSR program rev i sio n is due by July 20, 2015 for the 2008 ozone NAAQS. Accordingly , we are planning on adopting and s ubmittin g an NSR Rule and an Emis s ion Statements Rule by July , 2015
. Unt il EPA takes a final action to approve our new NSR program, we ack nowledge that the applicable requirements of 40 CFR part 51 , Appendix S apply to any new m a j o r so urce or m ajo r m od ifi cati o n of a m ajor so llrce, as defined therein, for sources em itting volatile organic co mpound s (V OC s) o r nitrogen oxides (NOx) as ozone precursors. Sincerely, 1



# _

J!/Jkiou



# bn~iih

Gretchen B e nnitt , Executiv e Dire ctor Northern Sierra Air Quality Management District

SERVING NEVADA, SIERRA AND PLUMAS COUNTIES
# C o u rt o f

A p p ea ls

o f t h e S t a te o f

G eo rg ia

ATLANTA,_

_ _ __ _ _ __ _ __ _ _ _ _ _ __ _

Th e Co u rt

o f Ap p ea l s h er eb y p a s s es t h e f

o ll owi n g o r der :

A2 1 A0 64 6 . MARCO J ILES v . THE STATE.

In 2 00 4

, M arco J i l es was co n v i ct ed of arm ed ro b b ery an d ag grav at ed as s au l t

,

an d t h i s Co u rt affi rm ed hi s co n v i ct i o n s

. Ji l es v. S t at e , Cas e N o

. A0 9 A1 5 11 (J u l y 1 7,

2 0 0 9 ). Sev eral y ears l at er, t h i s Co u rt d i s m is s ed J i l es ’ s ap p l i cat io n fo r d i s cret i o n ary

ap p eal o f t h e d i s m i s s al o f h is 20 1 6 m o ti o n t o v acat e a v o i d ju d g m en t

. Ji les v. S t a t e , Cas e No

. A1 7 D 0 3 1 8 (M arch 1 4, 2 0 1 7 ). In Decem ber 2 0 19

, J i l es fi l ed an o t h er m o t i o n

s eek i n g t o vacat e h is sen t en ce, arg u in g th at t h e t ri al co u rt s h o u l d h av e s en t en ced h i m

t o t h e m an d at o ry m i n im

u m o r l es s

. Th e t ri al co urt d i s m i s s ed t he m ot i o n o n Feb ru ary

2 8

, 2 0 2 0

. J i l es fi l ed b ot h an ap p l i cat io n fo r d i s cret i on ary ap p eal an d a n o t i ce o f d i rect

ap p eal fro m t h at ru l i ng

. Th is Co u rt d en i ed t he a p p l i cat i o n fo r d i s cret i on ary ap p eal

. S e e C a se No

. A2 0 D0 3 5 3 (d en i ed Ap ri l 1 6

, 2 0 2 0 ). W e, t herefo re, l ack ju ri s d i ct i o n

o v er t h i s d i rect ap p eal

. Ou r d e n i a l o f J i l es ’ s d i s cret i o n ary ap p l i cat i o n co n s ti t ut ed a d eci si o n o n t h e

m eri t s

. See El r o d v. S

u n f l o wer Mea d

o ws Dev., LLC

, 32 2 Ga. Ap p

. 6 6 6

, 6 7 0 (4 ) (7 4 5

SE2 d 8 4 6 ) (2 0 13 ) (“ [W ] h en t h i s Co u rt ex am i n es a req u es t fo r a di s cret i o n ary ap p eal

, i t a c t s i n an erro r-co rrect i n g m o d e s u ch th at a d en i al of t h e ap p l icat io n is o n t h e

m eri t s , an d t h e o rd er d en y i ng t h e ap p l i cat io n i s res ju d i cat a wi t h r e s p ect t o t h e

s u b s t an ce o f t h e req u es t ed rev i ew.”) (p u n ct u at i o n o m i t ted ). T h u s , t h e do ct ri n e o f res ju d i cat a b ars t h i s d irect ap p eal fro m t h e s am e ord er. See No r t h wes t S o ci a l & Ci vi c

Cl u b v. Fr a n kl in

, 2 7 6 Ga. 85 9

, 8 6 0 (5 8 3 SE2 d 85 8 ) (2 00 3 ); H o o k v. Ber g en , 2 8 6 Ga.
Ap p

. 2 5 8

, 2 6 1 (1 ) (6 4 9 SE2 d 3 13 ) (2 0 0 7 ). Th i s d i rect ap p eal i s hereb y DISM ISSED

fo r l ack o f ju ri s di ct i o n

. April 26, 2021C o u r t o f A p p e a l s o f t h e S t a t e o

f G e o r g ia

C le r k ’ s O f f i c e
, A t la n t a
,

_

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ I c e r t i f y t h a t t h e a b o v e i s a tr u e e x t r a c t f r o m

t h e m i n u t e s o

f t h e C o u r t o

f A p p e a l s o f G e o r g i a

.
W i tn e s s m y s i g n a t u r e a n d t h e s e a l o

f s a i d c o u r t
h e r e t o a f f i x e d t h e d a y a n d y e a r l a s t a b o v e w r i t t e n

.

, C l e r k

. 04/26/2021
Exhibit 23.1

                          Independent Auditors' Consent


The Board of Directors
CollaGenex Pharmaceuticals, Inc.:

We consent to the incorporation by reference in the registration statements (No.
333-31229,  No.  333-73230 and No.  333-112564) on Form S-8 and the registration
statements (No.  333-88697,  No. 333-35634,  No. 333-53766,  No. 333-58568,  No.
333-67044, No. 333-72166, No. 333-87556, No. 333-102773,  No. 333-103008 and No.
333-107918) on Form S-3 of CollaGenex Pharmaceuticals,  Inc. of our report dated
February 20, 2004, with respect to the consolidated balance sheets of CollaGenex
Pharmaceuticals, Inc. and subsidiaries as of December 31, 2003 and 2002, and the
related  consolidated  statements of operations,  stockholders'  equity and cash
flows for each of the years in the  three-year  period ended  December 31, 2003,
and the  related  financial  statement  schedule,  for each of the  years in the
three-year  period ended December 31, 2003, which report appears in the December
31, 2003 Annual Report on Form 10-K of CollaGenex Pharmaceuticals, Inc.

                                  /s/ KPMG LLP

Princeton, New Jersey
March 15, 2004
# Úradný vestník L 30/2020

| | ISSN 1977-0790 |
| --- | --- |
| Úradný vestník
  Európskej únie | L 30 |
| | |
| Slovenské vydanie | Právne predpisy | Ročník 633. februára 2020 |

ISSN 1977-0790

Úradný vestník

Európskej únie

L 30

Slovenské vydanie

Právne predpisy

Ročník 633. februára 2020

---

| Obsah | | Korigendá | Strana |
| --- | --- | --- | --- |
| | * | Korigendum k rozhodnutiu Rady (EÚ) 2019/1815 z 24. októbra 2019, ktorým sa vymenúvajú dvaja členovia a traja náhradníci Výboru regiónov navrhnutí Slovinskou republikou ( Ú. v. EÚ L 278, 30.10.2019 ) | 1 |

Obsah

Korigendá

Strana

*

Korigendum k rozhodnutiu Rady (EÚ) 2019/1815 z 24. októbra 2019, ktorým sa vymenúvajú dvaja členovia a traja náhradníci Výboru regiónov navrhnutí Slovinskou republikou ( Ú. v. EÚ L 278, 30.10.2019 )

( Ú. v. EÚ L 278, 30.10.2019 )

1

| SK | Akty, ktoré sú vytlačené obyčajným písmom, sa týkajú každodennej organizácie poľnohospodárskych záležitostí a sú spravidla platné len obmedzenú dobu.
  Názvy všetkých ostatných aktov sú vytlačené tučným písmom a je pred nimi hviezdička. |
| --- | --- |

SK

Akty, ktoré sú vytlačené obyčajným písmom, sa týkajú každodennej organizácie poľnohospodárskych záležitostí a sú spravidla platné len obmedzenú dobu.

Názvy všetkých ostatných aktov sú vytlačené tučným písmom a je pred nimi hviezdička.

---

Korigendá

| 3.2.2020 | SK | Úradný vestník Európskej únie | L 30/1 |
| --- | --- | --- | --- |

3.2.2020

SK

Úradný vestník Európskej únie

L 30/1

---

Korigendum k rozhodnutiu Rady (EÚ) 2019/1815 z 24. októbra 2019, ktorým sa vymenúvajú dvaja členovia a traja náhradníci Výboru regiónov navrhnutí Slovinskou republikou

(
  Úradný vestník Európskej únie L 278 z 30. októbra 2019
  )

Na strane 12 v článku 1 písm. b) prvej zarážke:

namiesto:

| „— | pán Aleksander Saša ARESNOVIČ, župan Mestne občine Maribor, |
| --- | --- |

„—

pán Aleksander Saša ARESNOVIČ, župan Mestne občine Maribor,

má byť:

| „— | pán Aleksander Saša ARSENOVIČ, župan Mestne občine Maribor,.“ |
| --- | --- |

„—

pán Aleksander Saša ARSENOVIČ, župan Mestne občine Maribor,.“

---